18F-FDG PET/CT

You have access
Is ¹⁸F-FDG PET/CT effective in identifying true residual disease after treatment of pediatric PTLD?
Batool El-Atoum, Mark Ebert, Brian Bucher and Zeinab Afify

Journal of Nuclear Medicine May 14, 2021, jnumed.121.262414; DOI: https://doi.org/10.2967/jnumed.121.262414
You have access
¹⁸F-FLT PET/CT Adds Value to ¹⁸F-FDG PET/CT for Diagnosing Relapse After Definitive Radiotherapy in Patients with Lung Cancer: Results of a Prospective Clinical Trial
Tine Nøhr Christensen, Seppo W. Langer, Gitte Persson, Klaus Richter Larsen, Annika Loft, Annemarie Gjelstrup Amtoft, Anne Kiil Berthelsen, Helle Hjorth Johannesen, Sune Høgild Keller, Andreas Kjaer and Barbara Malene Fischer

Journal of Nuclear Medicine May 10, 2021, 62 (5) 628-635; DOI: https://doi.org/10.2967/jnumed.120.247742
You have access
Clinical Utility of ¹⁸F-FDG PET/CT for Staging and Treatment Planning in Urachal Adenocarcinoma
Jeeban P. Das, Hebert A. Vargas, Soleen Ghafoor, Alvin C. Goh and Gary A. Ulaner

Journal of Nuclear Medicine May 10, 2021, 62 (5) 643-647; DOI: https://doi.org/10.2967/jnumed.120.251561
You have access
Humana and ¹⁸F-FDG PET/CT: Another Sequel to the Injustice of Being Judged by the Errors of Others
Johannes Czernin and Andrei Iagaru

Journal of Nuclear Medicine November 13, 2020, jnumed.120.260208; DOI: https://doi.org/10.2967/jnumed.120.260208
You have access
¹⁸F-FDG PET/CT Identifies Predictors of Survival in Patients with Locally Advanced Cervical Carcinoma and Paraaortic Lymph Node Involvement to Allow Intensification of Treatment
Hélène Leray, Erwan Gabiache, Frédéric Courbon, Isabelle Brenot-Rossi, Hélène Colineaux, Benoît Lepage, Eric Lambaudie, Alejandra Martinez, Marie Voglimacci, Ariane Weyl, Marion Deslandres, Anne Ducassou, Stéphanie Motton, Charlotte Vaysse and Elodie Chantalat

Journal of Nuclear Medicine October 1, 2020, 61 (10) 1442-1447; DOI: https://doi.org/10.2967/jnumed.119.238824
You have access
¹⁸F-FDG PET/CT in the Diagnostic and Treatment Evaluation of Pediatric Posttransplant Lymphoproliferative Disorders
Filipe M. Montes de Jesus, Andor W.J.M. Glaudemans, Wim J. Tissing, Rudi A.J.O. Dierckx, Stefano Rosati, Arjan Diepstra, Walter Noordzij and Thomas C. Kwee

Journal of Nuclear Medicine September 1, 2020, 61 (9) 1307-1313; DOI: https://doi.org/10.2967/jnumed.119.239624
You have access
¹⁸F-FDG PET Identifies Altered Brain Metabolism in Patients with Cri du Chat Syndrome
Angelina Cistaro, Natale Quartuccio, Arnoldo Piccardo, Piercarlo Fania, Marianna Spunton, Alexandra Liava, Cesare Danesino, Giovanni Albani and Andrea Guala

Journal of Nuclear Medicine August 1, 2020, 61 (8) 1195-1199; DOI: https://doi.org/10.2967/jnumed.119.236893
You have access
Imaging the Cancer Immune Environment and Its Response to Pharmacologic Intervention, Part 1: The Role of ¹⁸F-FDG PET/CT
Amir Iravani and Rodney J. Hicks

Journal of Nuclear Medicine July 1, 2020, 61 (7) 943-950; DOI: https://doi.org/10.2967/jnumed.119.234278
You have access
Hyperprogressive Disease in Patients with Non–Small Cell Lung Cancer Treated with Checkpoint Inhibitors: The Role of ¹⁸F-FDG PET/CT
Angelo Castello, Sabrina Rossi, Emanuela Mazziotti, Luca Toschi and Egesta Lopci

Journal of Nuclear Medicine June 1, 2020, 61 (6) 821-826; DOI: https://doi.org/10.2967/jnumed.119.237768
You have access
¹⁸F-FDG PET/CT as a Noninvasive Biomarker for Assessing Adequacy of Treatment and Predicting Relapse in Patients Treated for Pulmonary Tuberculosis
Ismaheel O. Lawal, Bernard P. Fourie, Matsontso Mathebula, Ingrid Moagi, Thabo Lengana, Nontando Moeketsi, Maphoshane Nchabeleng, Mark Hatherill and Mike M. Sathekge

Journal of Nuclear Medicine March 1, 2020, 61 (3) 412-417; DOI: https://doi.org/10.2967/jnumed.119.233783

Main menu

User menu

Search

18F-FDG PET/CT

Pages